We are live on ! Find out more
BHCM

Brevan Howard Capital Management Portfolio holdings

AUM $11.3B
1-Year Est. Return 35.84%
This Fund
S&P 500
This Quarter Est. Return
+6.99%
1 Year Est. Return
+35.84%
3 Year Est. Return
+106.49%
5 Year Est. Return
+80.14%
10 Year Est. Return
–
AUM
$14.4B
AUM Growth
+$3.17B
Cap. Flow
+$1.99B
Cap. Flow %
13.87%
Top 10 Hldgs %
75.34%
Holding
1,511
New
483
Increased
305
Reduced
301
Closed
405

Top Buys

Rank Stock Value
1
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$92.1M
2
MSFT icon
Microsoft
MSFT
+$81.2M
3
NVDA icon
NVIDIA
NVDA
+$77.3M
4
LLY icon
Eli Lilly
LLY
+$27.2M
5
SPOT icon
Spotify
SPOT
+$27.1M

Top Sells

Rank Stock Value
1
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$59M
2
AAPL icon
Apple
AAPL
+$50.2M
3
XLF icon
State Street Financial Select Sector SPDR ETF
XLF
+$33.8M
4
UNH icon
UnitedHealth
UNH
+$21.4M
5
SMCI icon
Super Micro Computer
SMCI
+$20.5M

Sector Composition

Rank Sector Weight
1 Technology 2.53%
2 Financials 2.03%
3 Industrials 1.57%
4 Healthcare 1.55%
5 Communication Services 1.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMI icon
801
Badger Meter
BMI
$3.95B
$332K ﹤0.01%
+1,519
New +$304K
THO icon
802
Thor Industries
THO
$4.14B
$329K ﹤0.01%
+2,998
New +$305K
CNMD icon
803
CONMED
CNMD
$1.48B
$329K ﹤0.01%
4,578
+1,251
+38% +$88.3K
PACB icon
804
Pacific Biosciences
PACB
$357M
$328K ﹤0.01%
192,956
-29,447
-13% -$48.4K
COLB icon
805
Columbia Banking Systems
COLB
$8.84B
$328K ﹤0.01%
12,553
-9,027
-42% -$215K
ARQT icon
806
Arcutis Biotherapeutics
ARQT
$3.26B
$327K ﹤0.01%
35,147
-52,683
-60% -$520K
BHVN
807
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$326K ﹤0.01%
+6,523
New +$326K
DNLI icon
808
Denali Therapeutics
DNLI
$4B
$325K ﹤0.01%
11,161
-18,196
-62% -$451K
PIPR icon
809
Piper Sandler
PIPR
$5.29B
$325K ﹤0.01%
+4,580
New +$300K
NVCR icon
810
NovoCure
NVCR
$2.02B
$325K ﹤0.01%
+20,777
New +$377K
IDXX icon
811
Idexx Laboratories
IDXX
$46.9B
$324K ﹤0.01%
+641
New +$311K
MGEE icon
812
MGE Energy Inc
MGEE
$3.04B
$324K ﹤0.01%
+3,540
New +$303K
ACT icon
813
Enact Holdings
ACT
$6.67B
$322K ﹤0.01%
+8,862
New +$302K
RELY icon
814
Remitly
RELY
$4.87B
$321K ﹤0.01%
23,969
+8,924
+59% +$121K
IOVA icon
815
Iovance Biotherapeutics
IOVA
$2.9B
$320K ﹤0.01%
34,121
+10,350
+44% +$98.1K
CENTA icon
816
Central Garden & Pet Co Class A
CENTA
$2.39B
$320K ﹤0.01%
+10,203
New +$339K
MD icon
817
Pediatrix Medical
MD
$2.12B
$320K ﹤0.01%
27,620
-9,277
-25% -$87.5K
WK icon
818
Workiva
WK
$3.66B
$320K ﹤0.01%
+4,044
New +$304K
AY
819
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
$319K ﹤0.01%
+14,503
New +$320K
ZD icon
820
Ziff Davis
ZD
$2B
$318K ﹤0.01%
+6,543
New +$312K
CFR icon
821
Cullen/Frost Bankers
CFR
$10.3B
$316K ﹤0.01%
+2,829
New +$309K
INVH icon
822
Invitation Homes
INVH
$17.8B
$316K ﹤0.01%
8,970
-1,681
-16% -$60.1K
EVGO icon
823
EVgo
EVGO
$224M
$316K ﹤0.01%
+76,395
New +$292K
WD icon
824
Walker & Dunlop
WD
$1.49B
$316K ﹤0.01%
+2,781
New +$291K
LITE icon
825
Lumentum
LITE
$63.3B
$315K ﹤0.01%
+4,974
New +$269K
31 32
33
34 35

Similar funds

GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
DCP
D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return
VLKIM
Van Lanschot Kempen Investment Management Amsterdam, Netherlands $11.4B AUM 16.77% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
ERSOT
Employees Retirement System of Texas Austin, Texas $11.4B AUM 21.6% 1-Year Est. Return
DWM
Dynasty Wealth Management St. Petersburg, Florida $11.5B AUM 15.23% 1-Year Est. Return
HTC
Haverford Trust Company Radnor, Pennsylvania $10.9B AUM 18.64% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Brevan Howard Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, Brevan Howard Capital Management held 1,511 positions worth $14.4B, up 28% from $11.2B the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Brevan Howard Capital Management deployed $1.99B of net new capital in Q3 2024, opening 483 new positions and adding to 305 existing holdings. Its largest new stake was iShares MSCI Emerging Markets ETF: 2,136,000 shares worth $98M.

By sector, the portfolio is most concentrated in Technology at 2.5% of assets, up from 2% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was UnitedHealth, an estimated $21.4M trimmed.

  • Brevan Howard Capital Management's largest Q3 2024 buy was iShares MSCI Emerging Markets ETF: 2,136,000 shares worth $98M.
  • Brevan Howard Capital Management added most to Eli Lilly in Q3 2024, an estimated $27.2M increase.
  • Brevan Howard Capital Management's biggest Q3 2024 reduction was UnitedHealth, cutting an estimated $21.4M.
  • Brevan Howard Capital Management fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2024, selling an estimated $59M.
  • Brevan Howard Capital Management's ten largest holdings make up 75% of its $14.4B portfolio in Q3 2024.
  • Brevan Howard Capital Management opened 483 new positions and closed 405 in Q3 2024.
  • Brevan Howard Capital Management's portfolio value rose 28% quarter-over-quarter to $14.4B.

Based on Brevan Howard Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.